Postmenopausal estrogen use affects risk for Parkinson disease. - Wikidata - awgldk - TriplyDB

Postmenopausal estrogen use affects risk for Parkinson disease.

Postmenopausal estrogen use affects risk for Parkinson disease.

http://www.wikidata.org/entity/Q30433773

about

Estrogen receptors and human disease Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration Sex differences in Parkinson's disease Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007 Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion The complexities of hormonal influences and risk of Parkinson's disease Mortality in levodopa-treated Parkinson's disease.Risk of Parkinson's disease after tamoxifen treatment.Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease Female reproductive factors, menopausal hormone use, and Parkinson's disease.Brain renin-angiotensin system and dopaminergic cell vulnerability Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.Estrogen-related and other disease diagnoses preceding Parkinson's disease Formulations of hormone therapy and risk of Parkinson's disease.Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies Neuroprotective strategies against calpain-mediated neurodegeneration.Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.Estrogen-BDNF interactions: implications for neurodegenerative diseases.Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Hormone replacement therapy and risk for neurodegenerative diseases.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Male/Female differences in neuroprotection and neuromodulation of brain dopamine Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson's Disease Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Estrogen receptor beta in health and disease.Variants in estrogen-related genes and risk of Parkinson's disease Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease Drug Insight: new drugs in development for Parkinson's disease.Diet, urate, and Parkinson's disease risk in men.Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Alzheimer's disease and other neurological disorders.Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease Use of estetrol with other steroids for attenuation of neonatal hypoxic-ischemic brain injury: to combine or not to combine?Understanding the broad influence of sex hormones and sex differences in the brain.Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?Estrogen agonist genistein differentially influences the cognitive and motor disorders in an ovariectomized animal model of Parkinsonism

P2860

Q24645374-1B3F0BBF-487F-41FD-8B33-C1DF29D233C9 Q27023974-64F65DBC-2AC4-4BE2-B6A4-6996AAC74787 Q27025107-16D47014-B64A-4FC0-B43A-93216DDD4CF3 Q28387116-465F2DE5-7927-4EC9-BD00-07FC0E39B1B9 Q28388388-D5490309-D26B-4A91-81D4-DF3099E77B37 Q28389039-E84E7E93-FA08-44DF-8152-6806EA766420 Q30414368-F4836D54-1570-44AD-BA6F-2F70F8766174 Q33552831-A3FAE7F9-92C0-4E40-AFE9-7EEF8CF15811 Q33740654-38BE13DB-CF5B-46B3-930A-6B79A12D53F3 Q33756791-AED92D33-36A9-4031-ABC5-618209090C1A Q33861951-E04FDEA9-2611-45B2-B294-FA0167A96217 Q33874635-0495A57C-BAC6-48E6-A5FB-3A69FF31C743 Q34144121-2DC11918-830F-46DC-A180-5ED8B2592674 Q34437648-C608876B-7F89-492A-A255-0DBE586942EF Q35049313-B09CC8DD-4C46-417C-9635-C378C6737E8A Q35081723-46E2A95D-812E-4FAB-BDC5-FFABE1F25D05 Q35230714-FAF01589-0982-4A9B-8C44-124A2709C992 Q35690176-9AC6D14C-1360-4641-9BE6-93754D94DFDB Q35806742-971075AD-19AD-48E5-BBAB-056D007BE859 Q35884815-A5D07426-B1AB-425F-831F-3FE7EE23A90A Q35971342-BA083C42-1E1F-4CD1-9262-1977F2A85859 Q35972056-2373FDC9-3E5D-41AA-A820-D78AC8CEC9D9 Q36067225-12DB3B58-4D1B-4BFE-841F-68C4C349509E Q36102771-F9318403-4B09-4552-AD5C-69397C59EBF9 Q36202013-C5FF6713-029D-4E0E-B46C-0CEEC406EBF0 Q36491681-629FE0C2-0679-486F-B4F2-AD3AAC108B7B Q36576487-71807C2D-BA96-4C64-9549-445B992959C8 Q36631654-6A51E3EE-C814-4E63-9F56-C59A80385BBA Q36632177-A947A5E9-AB91-4D7A-8933-7FB036F1C3E1 Q36805092-D9AE8781-CE8E-41B2-95E5-D19144CAF8B9 Q36854132-B3BD5577-90B7-485B-9BED-44C12FB06B0F Q36946824-BA285F1A-B30C-4C8E-9F1D-958D73C90078 Q37044339-26C316D3-61BD-4968-A2C5-192654F381FC Q37057444-E0A1A2FB-6FFC-4721-A565-E3D1162E9206 Q37273506-F6B9DDEA-A865-48B8-AB54-AD7495011CDF Q37362137-1487C629-9E6F-4FAE-ABD5-6FBA21B5A1C8 Q37376143-585B591F-A4E8-49B1-A950-7959636DE5F2 Q37432206-EFA70C05-6CB9-4C0A-A343-0D8FD3DCE0A6 Q37514014-25D7B272-1F32-4183-B734-B3945015F0C5 Q37570882-8A43F865-AFD0-43A5-A19C-0829E71D8CA2

P2860

Postmenopausal estrogen use affects risk for Parkinson disease.

http://www.wikidata.org/entity/Q30433773

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Postmenopausal estrogen use affects risk for Parkinson disease.

@ast

Postmenopausal estrogen use affects risk for Parkinson disease.

@en

type

label

Postmenopausal estrogen use affects risk for Parkinson disease.

@ast

Postmenopausal estrogen use affects risk for Parkinson disease.

@en

prefLabel

Postmenopausal estrogen use affects risk for Parkinson disease.

@ast

Postmenopausal estrogen use affects risk for Parkinson disease.

@en

P1433

Q30433773-63E5C642-AB40-4FC8-89F7-4534B0993D24

P1476

Q30433773-FECDF679-D361-466C-BB00-5FF45DC44607

P2093

Q30433773-1C0CA902-6A28-4168-82A1-58ECD90EBDBC

Q30433773-83E260EE-B1D2-48BC-B95E-53DEF0FE9B9E

Q30433773-C07C0D7D-0317-4E6E-811D-2C3B1867EA78

Q30433773-DB659C43-DF3E-40DD-9DD7-12853B8225F8

Q30433773-DB750A1C-F241-4FC1-BE37-7625DD94DFD4

P304

Q30433773-3D85E262-A2E4-4552-9ADE-0B59E8BE9A70

P31

Q30433773-6374C7DD-8E90-496F-B0DD-4BDD3A094146

P356

Q30433773-4391410B-FF4B-4839-A4A5-252BD6E01663

P433

Q30433773-F6D24AF3-0BE5-4BB5-BB23-6B43FD9EE255

P478

Q30433773-25D35D78-73EC-41EA-9F14-F82DA31C55EF

P577

Q30433773-5E18684B-2765-40C4-BCD0-F01B55EE8680

P698

Q30433773-76D90208-7480-4BD5-BF4B-3B94CF52EA39

P921

Q30433773-CC99861B-C61F-4152-8BB3-6F251E2DEE8F

P356

ARCHNEUR.61.6.886

P1433

P1476

Postmenopausal estrogen use affects risk for Parkinson disease.

@en

P2093

G Frederick Wooten

http://www.w3.org/2001/XMLSchema#string

James P Bennett

http://www.w3.org/2001/XMLSchema#string

Joel M Trugman

http://www.w3.org/2001/XMLSchema#string

Lillian J Currie

http://www.w3.org/2001/XMLSchema#string

Madaline B Harrison

http://www.w3.org/2001/XMLSchema#string

P304

886-888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHNEUR.61.6.886

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15210525

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease